remaining strong. Rotterdam PTA expansion required a tie-in shutdown lowering PTA production by 45KT. European market is displaying strength which continues in 3Q17 therefore the doubling of PTA output to
product quality (the company has been awarded ISO 13485, the Quality Management System for Medical Device Industry), which is an important tool in the competition and expansion of the market in the future
the year 2019, leading to the revenue dropped of Baht 28.83 million or 30.03% Other Revenues Other revenues, including interest income, gain on foreign exchange and other income, amounted to Baht 4.56
collections to market as Festive collection with a collaboration in design with a leading lifestyle product manufacturer; Santé collection with a new choice of modern design for hotel and restaurant. Also, one
than in 2017 which mainly supported by acceleration of global economy growth. Moreover, expansion in private consumption, export growth, and private investment from last year was due to higher consumer
from 2.3% in the second quarter of 2019, mainly driven by expansion of private consumption, government spending and tourism sector. Meanwhile, exports sector continued to contract caused by uncertainty
2018 primarily due to the US-China trade war and global uncertainty contributed negative impact on export growth. The growth of credit card business in Thailand continue expansion due to overall economic
plan regarding the expansion of biodiesel business of the Company. Details of the Board of Directors’ opinion and details of the capital increase and the allocation of the newly issued ordinary shares
. 3) Gradual expansion of private consumption as consumer confidence continues to improve and 4) Other supporting factors, namely public and private investments and proposed stimulus schemes, such as
% YoY but flat QoQ. The increase YoY was mainly from partnership with TOT. Excluding the TOT cost, network OPEX increased 10% YoY from network expansion in both mobile and broadband but dropped 1.6% QoQ